File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.

TitleRepression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.
Authors
Han, STang, QZheng, FZhao, SYChen, JWang, Z
KeywordsAMPKα
Ciglitazone
Egr-1
Human lung adenocarcinoma cell
Metformin
PDK1
Issue Date2014
PublisherBioMed Central Ltd. The Journal's web site is located at http://www.molecular-cancer.com
Citation
Molecular cancer, 2014, v. 13, article no. 149 How to Cite?
DOI: http://dx.doi.org/10.1186/1476-4598-13-149
Persistent Identifierhttp://hdl.handle.net/10722/199588
ISSN
1476-4598
2021 Impact Factor: 41.444
2020 SCImago Journal Rankings: 7.274
PubMed Central ID
PMC4061523
ISI Accession Number ID
WOS:000338262400001

 

DC FieldValueLanguage
dc.contributor.authorHan, Sen_US
dc.contributor.authorTang, Qen_US
dc.contributor.authorZheng, Fen_US
dc.contributor.authorZhao, SYen_US
dc.contributor.authorChen, Jen_US
dc.contributor.authorWang, Zen_US
dc.date.accessioned2014-07-22T01:24:28Z-
dc.date.available2014-07-22T01:24:28Z-
dc.date.issued2014en_US
dc.identifier.citationMolecular cancer, 2014, v. 13, article no. 149en_US
dc.identifier.issn1476-4598-
dc.identifier.urihttp://hdl.handle.net/10722/199588-
dc.languageengen_US
dc.publisherBioMed Central Ltd. The Journal's web site is located at http://www.molecular-cancer.com-
dc.relation.ispartofMolecular canceren_US
dc.rightsMolecular cancer. Copyright © BioMed Central Ltd.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAMPKα-
dc.subjectCiglitazone-
dc.subjectEgr-1-
dc.subjectHuman lung adenocarcinoma cell-
dc.subjectMetformin-
dc.subjectPDK1-
dc.titleRepression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.en_US
dc.typeArticleen_US
dc.identifier.emailChen, J: abchen@hku.hken_US
dc.identifier.emailWang, Z: wangzy@hku.hken_US
dc.identifier.authorityChen, J=rp01316en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/1476-4598-13-149-
dc.identifier.pmid24925061-
dc.identifier.pmcidPMC4061523-
dc.identifier.scopuseid_2-s2.0-84902055951-
dc.identifier.hkuros231256en_US
dc.identifier.volume13-
dc.identifier.isiWOS:000338262400001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1476-4598-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats